Carisma Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 3.5%.

Top 25 shareholders own 58.72% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
12.1%	Moderna, Inc.	5,059,338	US$4.3m	0%	no data
8.14%	Odlander, Fredrikson & Co. AB	3,398,248	US$2.9m	0%	2.88%
6.59%	AbbVie Inc.	2,749,855	US$2.3m	0%	no data
5.86%	Longview Innovation Corp.	2,445,368	US$2.1m	0%	no data
5.5%	Regina Hodits	2,297,546	US$1.9m	0%	no data
5.31%	Chidozie Ugwumba	2,215,877	US$1.9m	0%	no data
3.47%	The Vanguard Group, Inc.	1,448,247	US$1.2m	0%	no data
3%	University of Pennsylvania, Endowment Arm	1,252,107	US$1.1m	0%	1.57%
1.34%	TPG Capital, L.P.	561,442	US$476.0k	-33.3%	no data
1.32%	Barclays PLC Private Banking & Investment Banking Investment	549,305	US$465.7k	3,660,000%	no data
1.16%	Michael Klichinsky	484,347	US$410.6k	0%	no data
0.98%	BlackRock, Inc.	408,564	US$346.4k	-42.5%	no data
0.77%	JEC II Associates LLC	319,991	US$271.3k	0%	9.01%
0.64%	Ipg Usa Sco Lp	267,864	US$227.1k	0%	no data
0.62%	Geode Capital Management, LLC	259,184	US$219.7k	-8.55%	no data
0.5%	Renaissance Technologies LLC	206,757	US$175.3k	48.4%	no data
0.34%	Millennium Management LLC	142,522	US$120.8k	-11%	no data
0.24%	Michael Torok	101,250	US$85.8k	0%	no data
0.2%	State Street Global Advisors, Inc.	85,106	US$72.2k	0%	no data
0.18%	Northern Trust Global Investments	75,451	US$64.0k	-66.4%	no data
0.15%	Bridgeway Capital Management, LLC	60,876	US$51.6k	5.09%	no data
0.084%	Wexford Capital LP	34,861	US$29.6k	75.5%	0.01%
0.082%	Two Sigma Investments, LP	34,141	US$28.9k	0%	no data
0.079%	Bg Fund Management Luxembourg S.A.	32,819	US$27.8k	0%	no data
0.06%	Blodgett Wealth Advisors, LLC	25,001	US$21.2k	-1.96%	0.02%